Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials
Background: Colchicine is well known drug for the treatment of acute gout. Recently, it has also been used in the management of COVID-19 patients. Aim: The aim of current study is to find out the role of colchicine in COVID-19 patients. Material & methods: The relevant studies were searched...
Main Authors: | Avinash Kumar Singh, Arya Vidyadhari, Harmandeep Singh, Kashif Haider, Anoop Kumar, Manju Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Clinical Epidemiology and Global Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213398422001397 |
Similar Items
-
Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses
by: Mohammed I. Danjuma, et al.
Published: (2023-10-01) -
The role of colchicine in the management of COVID-19: a Meta-analysis
by: Kholoud Elshiwy, et al.
Published: (2024-04-01) -
What is the lowest lethal dose of colchicine?
by: Vanyo Mitev
Published: (2023-11-01) -
Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01) -
Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis
by: Chi-Hone Lien, et al.
Published: (2021-08-01)